StanburyJB. 1991. A Constant Ferment: A History of the Thyroid Clinic Laboratory at the Massachusetts General Hospital: 1913–1990. The Ipswich Press: Ipswich, Massachusetts.
2.
StanburyJB. 1958. Iodine metabolism and physiological aspects of endemic goitre. Bulletin of the World Health Organization, 18:201–215.
3.
StanburyJB, WyngaardenJB, FredricksonDS. 1978. The Metabolic Basis of Inherited Disease. 4th. McGraw-Hill: New York.
4.
HamolskyMW, GolodetzA, FreedbergAS. 1959. The plasma protein-thyroid hormone complex in man. III. Further studies on the use of the in vitro red blood cell up take of I 131-1-triiodothyronine as a diagnostic test of thyroid function. J Clin Endocrinol Metab, 19:103–116.
5.
WalfishPG, BrittonA, VolpeR, EzrinC. 1961. Experience with an in vitro test of thyroid function—the red blood cell uptake of L-triiodothyronine labelled with radioactive iodine. Can Med Assoc J, 84:637–641.
6.
WalfishPG, BrittonA, VolpeR, EzrinC. 1962. Quantitative plasma binding capacity studies of thyroxine-binding globulin by use of a modification of the erythrocyte 1-triiodothyronine-1-131 uptake test. J Clin Endocrinol Metab, 22:178–186.
7.
WalfishPG, MiskinM, RosenIB, StrawbridgeHT. 1976. Application of special diagnostic techniques in the management of nodular goitre. Can Med Assoc J, 115:35–40.
8.
WalfishPG, HazaniE, StrawbridgeHT, MiskinM, RosenIB. 1977. Combined ultrasound and needle aspiration cytology in the assessment and management of hypofunctioning thyroid nodule. Ann Intern Med, 87:270–274.
9.
RosenIB, ProviasJP, WalfishPG. 1986. Pathologic nature of cystic thyroid nodules selected for surgery by needle aspiration biopsy. Surgery, 100:606–613.
10.
GinsbergJ, YoungJE, WalfishPG. 1978. Parathyroid cysts. Medical diagnosis and management. JAMA, 240:1506–1507.
MiskinM, RosenIB, WalfishPG. 1973. B-mode ultrasonography in assessment of thyroid gland lesions. Ann Intern Med, 79:505–510.
13.
MiskinM, RosenIB, WalfishPG. 1975. Ultrasonography of the thyroid gland. Radiol Clin North Am, 13:479–492.
14.
WalfishPG. 1976. Triiodothyronine and thyroxine interrelationships in health and disease. Can Med Assoc J, 115:338–342.
15.
WalfishPG. 1976. Evaluation of three thyroid-function screening tests for detecting neonatal hypothyroidism. Lancet, 1:1208–1210.
16.
WalfishPG, GinsbergJ, RosenbergRA, HowardNJ. 1979. Results of a regional cord blood screening programme for detecting neonatal hypothyroidism. Arch Dis Child, 54:171–177.
17.
PriceDA, EhrlichRM, WalfishPG. 1981. Congenital hypothyroidism. Clinical and laboratory characteristics in infants detected by neonatal screening. Arch Dis Child, 56:845–851.
18.
WalfishPG, GeraE. 1980. Experience with the application of a dried blood thyrotropin (TSH) method for neonatal hypothyroidism screening: comparative studies between double antibody, solid phase radioimmunoassays. BickelH, GuthrieR, HammersenG. Neonatal Screening for Inborn Errors of Metabolism. Springer-Verlag: Berlin, Heidelberg, New York, 219–228.
19.
WalfishPG, GeraE, WoodMM. 1981. Problems in screening for congenital hypothyroidism using thyroxine assays from small dried blood discs. J Nucl Med, 22:818–823.
20.
WalfishPG, WoodMM. 1981. Cut-off for supplementary TSH testing in a T4 screening program for congenital hypothyroidism. J Pediatr, 99:164–167.
WalfishPG, MeyersonJ, ProviasJP, VargasMT, PapsinFR. 1992. Prevalence and characteristics of post-partum thyroid dysfunction: results of a survey from Toronto, Canada. J Endocrinol Invest, 15:265–272.
23.
VargasMT, Briones-UrbinaR, GladmanD, PapsinFR, WalfishPG. 1988. Antithyroid microsomal autoantibodies and HLA-DR5 are associated with postpartum thyroid dysfunction: evidence supporting an autoimmune pathogenesis. J Clin Endocrinol Metab, 67:327–333.
24.
WalfishPG, YoganathanT, YangYF, HongH, ButtTR, StallcupMR. 1997. Yeast hormone response element assays detect and characterize GRIP1 coactivator-dependent activation of transcription by thyroid and retinoid nuclear receptors. Proc Natl Acad Sci USA, 94:3697–3702.
25.
AnafiM, YangYF, BarlevNA, GovindanMV, BergerSL, ButtTR, WalfishPG. 2000. GCN5 and ADA adaptor proteins regulate triiodothyronine/GRIP1 and SRC-1 coactivator-dependent gene activation by the human thyroid hormone receptor. Mol Endocrinol, 14:718–732.
26.
MengX, YangYF, CaoX, GovindanMV, ShuenM, HollenbergAN, MymrykJS, WalfishPG. 2003. Cellular context of coregulator and adaptor proteins regulates human adenovirus 5 early region 1A-dependent gene activation by the thyroid hormone receptor. Mol Endocrinol, 17:1095–1105.
27.
MengX, WebbP, YangYF, ShuenM, YousefAF, BaxterJD, MymrykJS, WalfishPG. 2005. E1A and a nuclear receptor corepressor splice variant (N-CoRI) are thyroid hormone receptor coactivators that bind in the corepressor mode. Proc Natl Acad Sci USA, 102:6267–6272.
HallFT, BeasleyNJ, EskiSJ, WitterickIJ, WalfishPG, FreemanJL. 2003. Predictive value of serum thyroglobulin after surgery for thyroid carcinoma. Laryngoscope, 113:77–81.
30.
SawkaAM, OrlovS, GelbergJ, StorkB, DowarM, ShaytzagM, TabatabaieV, FreemanJL, WalfishPG. 2008. Prognostic value of postsurgical stimulated thyroglobulin levels after initial radioactive iodine therapy in well-differentiated thyroid carcinoma. Head Neck, 30:693–700.
31.
OrlovS, OrlovD, ShaytzagM, DowarM, TabatabaieV, DwekP, YipJ, HuC, FreemanJL, WalfishPG. 2009. Influence of age and primary tumor size on the risk for residual/recurrent well-differentiated thyroid carcinoma. Head Neck, 31:782–788.
32.
VaismanA, OrlovS, YipJ, HuC, LimT, DowarM, FreemanJL, WalfishPG. 2010. Application of post-surgical stimulated thyroglobulin for radioiodine remnant ablation selection in low-risk papillary thyroid carcinoma. Head Neck, 32:689–698.
